Come up with a name for your new list and we'll add to it:
Harbour Antibodies was acquired by
Harbour BioMed on December 19, 2016.
Harbour Antibodies is enabling the development of new therapeutic human monoclonal antibodies through the creation of two lines of transgenic mice. The H2L2 mice, which generate full IgG and the HCAb …